Pulmatrix Inc. has entered into a merger agreement with Cullgen Inc., where Cullgen will become a wholly owned subsidiary of Pulmatrix, with Cullgen shareholders owning approximately 96.4% of the combined company post-merger, and Pulmatrix plans to declare a cash dividend of excess net cash above $2.5 million to its shareholders before the merger closes.